results with the boston type i keratoprosthesis after acanthamoeba keratitis
Clicks: 457
ID: 142350
2017
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
30.0
/100
457 views
44 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #7 of 58 articles by views in contemporary clinical trials communications
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Purpose: To report the outcomes of implantation of the Boston Type I keratoprosthesis in three patients with Acanthamoeba keratitis (AK), a severe infection that can lead to significant visual loss.
Observations: Case series reporting three patients with difficult cases of AK that needed multiple corneal transplantations and glaucoma surgeries. All patients were implanted with the Boston Type I keratoprosthesis device. The main outcomes measure were the visual function and anatomical retention after implantation of the Boston Type I keratoprosthesis. All patients retained the device over the long-term and had good visual function. In one patient a retroprosthetic membrane developed and in another patient an epithelial lip developed over the anterior surface of the keratoprosthesis. The visual acuities range from 20/25 to 20/80 in the implanted eyes.
Conclusions and importance: The Boston Type I keratoprosthesis resulted in good anatomic and functional results after multiple graft failures after AK.
| Reference Key |
santos2017americanresults
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Albert Santos;Luzia Diegues Silva;Luciene Barbosa de Sousa;Denise de Freitas;Lauro Augusto de Oliveira |
| Journal | contemporary clinical trials communications |
| Year | 2017 |
| DOI |
10.1016/j.ajoc.2017.01.007
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.